Latest News and Press Releases

MONTRÉAL, 23 janv. 2021 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal (ICM) annonce aujourd’hui que l’étude clinique COLCORONA a fourni des résultats cliniquement convaincants de...

MONTREAL, Jan. 23, 2021 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy...

MONTRÉAL, 22 janv. 2021 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal (ICM) annonce aujourd’hui que l’étude clinique COLCORONA a fourni des résultats cliniquement convaincants de...

MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy...

MONTREAL, Dec. 03, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) has announced that colchicine, a widely available low-cost drug, reduces acute lung injury (ALI), acute respiratory...

Montréal, 28 nov. 2020 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal (ICM) annonce aujourd’hui que l’étude clinique COLCORONA continuera de recruter des patients adultes...

MONTREAL, Nov. 28, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) today announced that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with...

MONTRÉAL, 26 juin 2020 (GLOBE NEWSWIRE) -- L'Institut de Cardiologie de Montréal annonce aujourd'hui que l’étude clinique COLCORONA continuera de recruter des patients adultes non-hospitalisés...

MONTREAL, June 26, 2020 (GLOBE NEWSWIRE) -- Montreal Heart Institute today announced that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with COVID-19 as...

MONTREAL and WALTHAM, Mass., June 16, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) and Thermedical®, a developer of thermal-ablation systems to treat ventricular arrhythmias, today...